Minoryx to validate MIN-102 with Series A funding
14 October 2015 | By Victoria White
A Series A funding round of €19.4M will see Minoryx Therapeutics move its lead project MIN-102 to clinical validation for X-linked adrenoleukodystrophy (X-ALD)...
List view / Grid view
News
UCL and Takeda to identify targets for neurodegenerative diseases
14 October 2015 | By Victoria White
The three-year collaboration will focus on mechanistic approaches for the identification of genes or signalling pathways that modify neurodegenerative disease processes affecting neuronal health...
Researchers develop animal-free renal screening platform
13 October 2015 | By Victoria White
Researchers have developed the first animal-free screening platforms capable of predicting the toxic effects of compounds on the human kidney accurately...
Malaria vaccine provides hope for a cure for cancer
13 October 2015 | By Victoria White
Scientists have created a malaria protein with a toxin seeks out cancer cells. The protein is absorbed, the toxin released inside, and then the cancer cells die...
Lilly and ImaginAb to investigate imaging agent in immuno-oncology therapies
13 October 2015 | By Victoria White
ImaginAb will conduct preclinical research using its immune imaging agent, IAB22M2C, to detect T-cell trafficking, redirection and infiltration in response to Lilly oncology molecules...
Exon skipping demonstrates success in severe form of muscular dystrophy
13 October 2015 | By Victoria White
An RNA editing technique called "exon skipping" has demonstrated preliminary success in treating Limb Girdle Muscular Dystrophy Type 2C in a new study...
Tamoxifen beats MRSA superbug in mice models
13 October 2015 | By Victoria White
Researchers have found that tamoxifen gives white blood cells a boost, better enabling them to respond to and kill bacteria in laboratory experiments...
Asterias collaborates with Cell Therapy Catapult to scale production of AST-VAC2
13 October 2015 | By Victoria White
AST-VAC2 is an immunotherapy product that contains mature dendritic cells derived from pluripotent stem cells...
Collaboration to investigate acute myeloid leukaemia therapeutic approaches
12 October 2015 | By Victoria White
Boehringer Ingelheim and Philogen have agreed on an exploratory trial investigating novel immunotherapy concepts for relapsed acute myeloid leukaemia patients...
Cancer Research UK launches the Grand Challenge to help beat cancer
12 October 2015 | By Victoria White
International scientists across all disciplines are invited to come up with solutions to seven challenges which cover some of the most important unanswered questions in cancer research...
Astex Pharmaceuticals joins The Dementia Consortium
12 October 2015 | By Victoria White
The Dementia Consortium is a £3.5m drug discovery collaboration between Alzheimer’s Research UK, MRC Technology, Eisai, Lilly and now Astex...
Lilly and Innovent expand anti-PD-1 bispecific antibody collaboration
12 October 2015 | By Victoria White
As part of the expanded collaboration, Innovent could receive additional milestones totalling more than $1 billion if the products reach certain milestones...
3SBio enters licensing deal for antibody-drug conjugate ALT-P7
12 October 2015 | By Victoria White
Preclinical proof-of-concept has demonstrated superiority of ALT-P7 over current drugs in murine models of HER2-positive breast cancer...
Lilly announces New York R&D site expansion
12 October 2015 | By Victoria White
Lilly has announced plans to add 30,000 square feet to its research and development site at the Alexandria Centre for Life Science in New York...
Eyevensys completes €7.5m Series A financing to develop EYS606
9 October 2015 | By Victoria White
The Company is developing EYS606, an innovative combination product associating a DNA plasmid encoding a therapeutic protein with an injection-electroporation device, for the treatment of Non-Infectious Posterior Uveitis...